Impact of complete revascularization with percutaneous coronary intervention on survival in patients with at least

Renato Valenti1, Angela Migliorini, Umberto Signorini

  • 1Division of Cardiology, Careggi Hospital, Viale Pieraccini, I-50134 Florence, Italy.

European Heart Journal
|August 7, 2008
PubMed

Insights

Successful drug-eluting stent percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) improves long-term cardiac survival. This survival benefit is most pronounced in patients with multivessel disease who achieve complete revascularization.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Chronic total occlusion (CTO) poses a significant challenge in coronary artery disease management.
  • Percutaneous coronary intervention (PCI) using drug-eluting stents (DES) is a primary revascularization strategy for CTO.
  • The long-term survival impact of successful CTO-PCI remains an area of active investigation.

Purpose of the Study:

  • To evaluate the effect of successful drug-eluting stent-supported PCI on long-term survival in patients with CTO.
  • To compare cardiac survival rates between successful and failed CTO-PCI procedures.
  • To identify patient subgroups benefiting most from successful CTO-PCI.

Main Methods:

  • Retrospective analysis of consecutive patients undergoing PCI for at least one CTO between 2003 and 2006.
  • Stratification of patients into successful (71%) and failure CTO-PCI groups.
  • Comparison of long-term cardiac survival, considering factors like multivessel disease and complete revascularization.

Main Results:

  • Successful CTO-PCI was achieved in 71% of patients and 68% of lesions.
  • Long-term cardiac survival was significantly higher in the successful CTO-PCI group (91.6%) compared to the failure group (87.4%; P = 0.025).
  • Patients with multivessel disease and complete revascularization in the success group showed superior survival rates (94.0%) versus incomplete revascularization (83.8%; P < 0.001).

Conclusions:

  • Successful drug-eluting stent-supported CTO-PCI significantly improves long-term cardiac survival.
  • The survival benefit is particularly evident in patients with multivessel disease who undergo complete revascularization.
  • CTO-PCI success is a critical determinant of favorable long-term outcomes in selected patient populations.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...